The American Psychiatric Association (APA) has updated its Privacy Policy and Terms of Use, including with new information specifically addressed to individuals in the European Economic Area. As described in the Privacy Policy and Terms of Use, this website utilizes cookies, including for the purpose of offering an optimal online experience and services tailored to your preferences.

Please read the entire Privacy Policy and Terms of Use. By closing this message, browsing this website, continuing the navigation, or otherwise continuing to use the APA's websites, you confirm that you understand and accept the terms of the Privacy Policy and Terms of Use, including the utilization of cookies.

×
Published Online:https://doi.org/10.1176/foc.7.4.foc441

Insomnia is experienced by nearly one-third of the population over the course of a year. It affects many dimensions of daily human function. Although its pathophysiology is poorly understood, it is felt to be the final product of excessive arousal in multiple neurophysiological and psychological systems. Because it can coexist with a wide variety of medical and psychiatric disorders, the first task of the clinician in the management of this condition is to engage in a comprehensive evaluation to identify comorbid disorders. Once these are identified, specific treatment can be conducted with confidence. A variety of cognitive/behavioral and pharmacological management techniques are also available for primary insomnia.